DK165901C - Stabiliserede injektionsoploesninger af piroxicam - Google Patents

Stabiliserede injektionsoploesninger af piroxicam

Info

Publication number
DK165901C
DK165901C DK461385A DK461385A DK165901C DK 165901 C DK165901 C DK 165901C DK 461385 A DK461385 A DK 461385A DK 461385 A DK461385 A DK 461385A DK 165901 C DK165901 C DK 165901C
Authority
DK
Denmark
Prior art keywords
piroxicam
solutions
injection solutions
stabilized injection
stabilized
Prior art date
Application number
DK461385A
Other languages
Danish (da)
English (en)
Other versions
DK461385D0 (da
DK461385A (da
DK165901B (da
Inventor
Walter Fries
Original Assignee
Mack Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mack Chem Pharm filed Critical Mack Chem Pharm
Publication of DK461385D0 publication Critical patent/DK461385D0/da
Publication of DK461385A publication Critical patent/DK461385A/da
Publication of DK165901B publication Critical patent/DK165901B/da
Application granted granted Critical
Publication of DK165901C publication Critical patent/DK165901C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Finger-Pressure Massage (AREA)
DK461385A 1984-10-10 1985-10-09 Stabiliserede injektionsoploesninger af piroxicam DK165901C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19843437232 DE3437232A1 (de) 1984-10-10 1984-10-10 Stabilisierte injektionsloesungen von piroxicam
DE3437232 1984-10-10

Publications (4)

Publication Number Publication Date
DK461385D0 DK461385D0 (da) 1985-10-09
DK461385A DK461385A (da) 1986-04-11
DK165901B DK165901B (da) 1993-02-08
DK165901C true DK165901C (da) 1993-06-28

Family

ID=6247603

Family Applications (1)

Application Number Title Priority Date Filing Date
DK461385A DK165901C (da) 1984-10-10 1985-10-09 Stabiliserede injektionsoploesninger af piroxicam

Country Status (22)

Country Link
US (1) US4628053A (cs)
EP (1) EP0177870B1 (cs)
JP (1) JPS6191116A (cs)
KR (1) KR890001001B1 (cs)
CN (1) CN85107838B (cs)
AT (1) ATE62416T1 (cs)
AU (1) AU557184B2 (cs)
CA (1) CA1251734A (cs)
DD (1) DD238329A5 (cs)
DE (2) DE3437232A1 (cs)
DK (1) DK165901C (cs)
FI (1) FI84315C (cs)
GR (1) GR852439B (cs)
HU (1) HU195111B (cs)
IE (1) IE58267B1 (cs)
IL (1) IL76624A0 (cs)
NO (1) NO166687C (cs)
NZ (1) NZ213758A (cs)
PH (1) PH23058A (cs)
PT (1) PT81264B (cs)
SU (1) SU1482509A3 (cs)
ZA (1) ZA857783B (cs)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2545910B1 (fr) * 1983-05-11 1988-07-22 Valeo Dispositif pour ameliorer l'efficacite d'un echangeur de chaleur dans un boitier d'une installation de climatisation, et boitier de cette installation
IT1196307B (it) * 1984-10-22 1988-11-16 Chiesi Farma Spa Formulazioni farmaceutiche acquose di piroxicam monoidrato
US5807568A (en) * 1994-12-27 1998-09-15 Mcneil-Ppc, Inc. Enhanced delivery of topical compositions containing flurbiprofen
IT1283252B1 (it) * 1996-03-15 1998-04-16 Pulitzer Italiana Soluzioni di piroxicam iniettabili per via parenterale
WO1998001138A1 (fr) * 1996-07-04 1998-01-15 Nippon Kayaku Kabushiki Kaisha Injections de succinate sodique de methylprednisolone
US6136799A (en) * 1998-04-08 2000-10-24 Abbott Laboratories Cosolvent formulations
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10030345A1 (de) * 2000-06-20 2002-01-10 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
US8314124B2 (en) 2004-02-06 2012-11-20 Active Biotech Ab Crystalline salts of quinoline compounds and methods for preparing them
EP1568369A1 (en) * 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
DE102004021281A1 (de) * 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
SG166115A1 (en) * 2005-09-30 2010-11-29 Boehringer Ingelheim Vetmed Pharmaceutical preparation containing meloxicam
JP5832716B2 (ja) * 2005-10-19 2015-12-16 テバ ファーマシューティカル インダストリーズ リミティド ラキニモドナトリウムの結晶，及びその製造方法
AU2007258366B2 (en) 2006-06-12 2012-10-25 Active Biotech, Ab Stable laquinimod preparations
PL2682120T3 (pl) 2007-12-20 2017-02-28 Teva Pharmaceutical Industries, Ltd. Stabilne preparaty lakwinimodu
CN104311486A (zh) * 2008-09-03 2015-01-28 泰华制药工业有限公司 2-羰基-1,2-二氢喹啉免疫功能调节剂
JP5359333B2 (ja) * 2009-02-05 2013-12-04 ゼリア新薬工業株式会社 コロソリン酸含有水性液剤
DK2458992T3 (en) * 2009-07-30 2016-02-08 Teva Pharma Treatment of crohn's disease with laquinimod
EP3064206B1 (en) * 2009-08-10 2019-03-20 Active Biotech AB Treatment of huntington's disease using laquinimod
JP5559339B2 (ja) 2009-10-12 2014-07-23 ベーリンガー インゲルハイム フェトメディカ ゲゼルシャフト ミット ベシュレンクテル ハフツング メロキシカムを含む組成物のための容器
US9149480B2 (en) 2010-03-03 2015-10-06 Boehringer Ingeleheim Vetmedica GmbH Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US20110218191A1 (en) * 2010-03-03 2011-09-08 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long term-treatment of kidney disorders in cats
DE102010014290A1 (de) * 2010-04-08 2011-10-13 Hans Otto Meyer zu Spelbrink Mittel zur prophylaktischen und therapeutischen Behandlung von Herpes-Infektionen
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
AU2012322706A1 (en) 2011-10-12 2014-05-22 Teva Pharmaceutical Industries Ltd. Treatment of multiple sclerosis with combination of laquinimod and fingolimod
KR20140138694A (ko) 2012-02-03 2014-12-04 테바 파마슈티컬 인더스트리즈 리미티드 최선의 항-TNFα 요법에 실패한 크론병 환자를 치료하기 위한 라퀴니모드의 용도
TW201400117A (zh) 2012-06-05 2014-01-01 Teva Pharma 使用拉喹莫德治療眼發炎疾病
WO2014074381A1 (en) 2012-11-07 2014-05-15 Teva Pharmaceutical Industries Ltd. Amine salts of laquinimod
CN105051013A (zh) 2013-03-14 2015-11-11 泰华制药工业有限公司 拉喹莫德钠晶体及其改进的制造方法
KR101749425B1 (ko) * 2015-11-17 2017-06-22 연세대학교 산학협력단 난용성 약물의 서방형 제제
HUE068027T2 (hu) * 2017-08-09 2024-12-28 Dechra Veterinary Products Llc COX-2 inhibitort tartalmazó terápiás készítmények és alkalmazásuk

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE629650A (cs) * 1967-05-18 1900-01-01
US3591584A (en) * 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
DE2602363C2 (de) * 1976-01-22 1984-04-12 Bayer Ag, 5090 Leverkusen Wäßrige, injizierbare Niclofolan- Formulierungen
DE2756113A1 (de) * 1977-12-16 1979-06-21 Thomae Gmbh Dr K Neue 4-hydroxy-2h-1,2-benzothiazin- 3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE3217315C2 (de) * 1982-05-08 1986-05-22 Gödecke AG, 1000 Berlin Arzneimittelzubereitungen mit einem Gehalt an Oxicam-Derivaten
AT376879B (de) * 1982-10-27 1985-01-10 Gerot Pharmazeutika Verfahren zur herstellung einer injektionsloesung

Also Published As

Publication number Publication date
AU557184B2 (en) 1986-12-11
DK461385D0 (da) 1985-10-09
GR852439B (cs) 1986-02-10
NZ213758A (en) 1988-07-28
PT81264A (en) 1985-11-01
FI853926A0 (fi) 1985-10-09
HUT38541A (en) 1986-06-30
EP0177870B1 (de) 1991-04-10
HU195111B (en) 1988-04-28
FI853926L (fi) 1986-04-11
PT81264B (pt) 1988-02-17
ATE62416T1 (de) 1991-04-15
NO854011L (no) 1986-04-11
CA1251734A (en) 1989-03-28
IE852483L (en) 1986-04-10
EP0177870A2 (de) 1986-04-16
IE58267B1 (en) 1993-08-25
NO166687C (no) 1991-09-04
US4628053A (en) 1986-12-09
DK461385A (da) 1986-04-11
DD238329A5 (de) 1986-08-20
NO166687B (no) 1991-05-21
KR860003013A (ko) 1986-05-19
DE3582468D1 (de) 1991-05-16
AU4842185A (en) 1986-04-17
FI84315C (fi) 1991-11-25
SU1482509A3 (ru) 1989-05-23
CN85107838A (zh) 1986-07-09
JPS6191116A (ja) 1986-05-09
PH23058A (en) 1989-03-27
KR890001001B1 (ko) 1989-04-18
EP0177870A3 (en) 1987-06-03
JPH03849B2 (cs) 1991-01-09
ZA857783B (en) 1987-05-27
DK165901B (da) 1993-02-08
IL76624A0 (en) 1986-02-28
DE3437232A1 (de) 1986-04-17
FI84315B (fi) 1991-08-15
CN85107838B (zh) 1988-08-24

Similar Documents

Publication Publication Date Title
DK165901C (da) Stabiliserede injektionsoploesninger af piroxicam
SE8402560D0 (sv) Farmaceutisk komposition
IT8119321A0 (it) Procedimento per ottenere eparine di basso peso molecolare dotate di proprieta' farmacologiche elevate, e prodotto cosi' ottenuto.
BR9303469A (pt) Conjugado de interferon,composto,processo de preparacao de um conjugado de interferon,use e composicoes farmaceuticas
FR2518088B1 (fr) Nouveaux derives d'aminoacides, et leur application therapeutique
FI852995A0 (fi) Stabila salter av polyanioner innehaollande s-adenosyl-l-methionin (sam).
FI934000A0 (fi) Nya estrar av bi- och tricykliska aminoalkoholer, deras framstaellning och deras anvaendning i laekemedel
FI844677L (fi) Komposition och metod foer snabb upptaeckt av mikroorganismer i kliniska prover.
SE8505112D0 (sv) Novel pharmacological compounds
DE59208974D1 (de) Neue pyrazinderivative, ihre herstellung und verwendung
IT1145403B (it) Derivati di 1,2-diidro-2-osso-4-fenil-3-chinolin-carbonitrile dotati di proprieta' anti-infiammatorie
DE3863859D1 (de) Stabile, injizierbare loesungen von salzen von vincristin.
SE8600658D0 (sv) Novel composition of matter
DE3578597D1 (de) 4-phenylphthalazin-derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.
SE8902607L (sv) Oxaza heterocykler och pharmaceutiska kompositioner innehaallande densamma
DE68903670D1 (de) Physiologisch aktive, fluessige, allergenische zusammensetzungen aus biologischen rohmaterialien.
LV10289A (lv) Jauns pentapeptids ta iegusanas panemiens kompozicija sunu augsanas inhibesanai inhibesanas panemiens
GB985773A (en) Improvements in or relating to coated medicinals
IT8219587A0 (it) Derivati di apovincaminolo, relativo procedimento di preparazione e composizioni farmaceutiche contenenti glistessi.
CH585224A5 (en) Central-inhibitory and neuroleptic fluoro- tricyclic cpds. - prepd. by reacting a 10-halo-fluoro-substd. dibenzothiepin with a substd piperazine
FI905922A0 (fi) Antagonister foer a-adrenerga receptorer.
MY100229A (en) Topical anti-inflammatory compositions.
ATE44734T1 (de) 4-phenylpropylindolderivate und ihre salze, verfahren zur herstellung, deren anwendung als heilmittel und sie enthaltende pharmazeutische zusammensetzungen.
ATE1011T1 (de) 5-fluoruracil-derivate, deren herstellung und ihre pharmazeutischen zusammensetzungen.

Legal Events

Date Code Title Description
PBP Patent lapsed